Stocks · News reference

Standard BioTools Receives $30M Illumina Earnout And Royalty Buyout; Agrees To Sell Mass Cytometry Business For Up To $10M Ahead Of Treeline Merger

Jul 28, 2026, 12:06 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

LAB

Source: benzinga
Observed: Jul 28, 2026, 12:06 PM
Checked: Jul 28, 2026, 12:06 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 5, 2026, 8:16 PMBenzinga Newsdesk
Standard BioTools Q2 EPS $(0.07) Misses $(0.03) Estimate, Sales $20.104M Miss $20.805M Estimate
Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 22.22 percent increase over losses of $(0.09) per share
Read original at benzinga
LAB
SEC EDGARAug 5, 2026, 8:10 PMSEC EDGAR
8-K filing — STANDARD BIOTOOLS INC. (LAB)
Filed: 2026-08-05 AccNo: 0001193125-26-335106 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar
LAB
Globenewswire IncJun 19, 2026, 4:48 PMBrodsky & Smith
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB)
Brodsky & Smith law firm is investigating four merger transactions to determine whether company boards breached fiduciary duties to shareholders. The investigations concern AstroNova (being acquired by Arcline for $29.00/share), Open Lending (being acquired by ANV Group for $3.15/share), Huntsman (merging with Olin in a stock exchange), and Standard BioTools (being acquired by Treeline Biosciences). The firm is seeking shareholders to discuss whether fair processes were conducted and fair value provided.
Read original at globenewswire-inc
ALOT LPRO HUN LAB

Standard BioTools Receives $30M Illumina Earnout And Royalty Buyout; Agrees To Sell Mass Cytometry Business For Up To $10M Ahead Of Treeline Merger

Connected markets

Related headlines

Standard BioTools Q2 EPS $(0.07) Misses $(0.03) Estimate, Sales $20.104M Miss $20.805M Estimate

8-K filing — STANDARD BIOTOOLS INC. (LAB)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB)